| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $516.3M | +12.1% |
| Cost of Revenue | $417.3M | +19.7% |
| R&D Expense | $402.1M | -3.4% |
| SG&A Expense | $192.3M | -22.5% |
| Operating Income | -$3.12B | -696.2% |
| Interest Expense | $56.7M | +13.7% |
| Pre-tax Income | -$3.15B | -657.7% |
| Income Tax | -$44.9M | -21.8% |
| Net Income | -$3.11B | -719.6% |
| EPS (Basic) | -$13.18 | -632.2% |
| EPS (Diluted) | -$13.18 | -632.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.5M | -72.1% |
| Accounts Receivable | $96.1M | +45.2% |
| Inventory | $30.4M | -9.3% |
| Current Assets | $693.1M | -41.2% |
| Total Assets | $1.95B | -60.3% |
| Current Liabilities | $108.1M | -25.0% |
| Total Liabilities | $1.85B | -4.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$493.0M | +11.9% |
| Capital Expenditures | $53.3M | -2.6% |
| Investing Cash Flow | -$174.8M | +14.3% |
| Financing Cash Flow | $1.8M | -99.9% |
| Free Cash Flow | -$546.3M | +11.1% |
| Stockholders' Equity |
| $101.8M |
| -96.6% |